Global Custom Market Research Reports Provider Company

phone

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017

  • Published Date: 19 Jul 2017
  • Number of Pages: 149
  • Category: Healthcare and Medical
  • Country: Global
Critical Limb Ischemia Global Clinical Trials Review, H2, 2017

Summary

GlobalDatas clinical trial report, Critical Limb Ischemia Global Clinical Trials Review, H2, 2017" provides an overview of Critical Limb Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Critical Limb Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Publisher Name : GlobalData
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Critical Limb Ischemia Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Critical Limb Ischemia 38
Jul 10, 2017: Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at 40 Active Sites by the End of 2017 38
Clinical Trial Profile Snapshots 39
Appendix 146
Abbreviations 146
Definitions 146
Research Methodology 147
Secondary Research 147
About GlobalData 148
Contact Us 148
Source 148

List Of Tables


Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region, 2017* 8
Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15
Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 16
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 18
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 21
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 23
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 26
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase, 2017* 27
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 28
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 30
Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 33
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 35
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 37
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38

List Of Figures


Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 15
Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 16
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 17
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 22
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 27
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 28
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 33
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38
GlobalData Methodology 148

This report studies Critical Care Equipment in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions,

View Report

This report studies Supercritical Fluid Chromatography (Sfc) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these

View Report

In this report, the global Critical Care System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports